Total peripheral conductance mediates antihypertensive effect of nonpeptide mixed endothelin receptor antagonist in deoxycorticosterone acetate-salt hypertensive rats

被引:4
|
作者
Yu, M
Gopalakrishnan, V
McNeill, JR [1 ]
机构
[1] Univ Saskatchewan, Coll Med, Dept Pharmacol, Saskatoon, SK S7N 5E5, Canada
[2] Univ Saskatchewan, Coll Med, Cardiovasc Risk Factor Reduct Unit, Saskatoon, SK S7N 5E5, Canada
基金
英国医学研究理事会;
关键词
endothelin; DOCA-salt hypertension; hemodynamics; blood pressure; cardiac output; total peripheral resistance; endothelin antagonist;
D O I
10.1016/S0895-7061(99)00055-2
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The relative contribution of cardiac output (CO) and total peripheral conductance (TPC) to the changes in blood pressure (BP) evoked by an intravenous injection of bosentan, a nonpeptide mixed endothelin (ET) antagonist, were investigated in conscious unrestrained deoxycorticosterone acetate (DOCA)-salt hypertensive rats and sham-control rats. Blood pressure was recorded by radiotelemetry devices and CO by ultrasonic transit-time now probes. Bosentan significantly reduced BP (from 141 +/- 3 to 111 +/- 3 mm Hg) and increased TPC (from 1.19 +/- 0.1 to 1.72 +/- 0.2 mL/min/kg/mm Hg) in DOCA-salt hypertensive rats, but not in sham rats. An increase in CO opposed the BP-lowering effect of the antagonist. The results demonstrate that the role of ET receptors in the maintenance of the hypertensive state in the DOCA-salt model of hypertension is exerted at the level of the resistance vessels and not on factors that regulate cardiac output. (C) 1999 American Journal of Hypertension, Ltd.
引用
收藏
页码:845 / 848
页数:4
相关论文
共 50 条
  • [1] Hemodynamic effects of a selective endothelin-A receptor antagonist in deoxycorticosterone acetate-salt hypertensive rats
    Yu, M
    Gopalakrishnan, V
    McNeill, JR
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S262 - S264
  • [2] Microvascular responses to endothelin in deoxycorticosterone acetate-salt hypertensive rats
    Zhao, HL
    Joshua, IG
    Porter, JP
    AMERICAN JOURNAL OF HYPERTENSION, 2000, 13 (07) : 819 - 826
  • [3] Effect of an endothelin antagonist on vascular responsiveness to vasopressin and angiotensin II in deoxycorticosterone acetate-salt hypertensive rats
    McNeill, JR
    Yu, M
    Gopalakrishnan, V
    JOURNAL OF HYPERTENSION, 2000, 18 : S131 - S131
  • [4] ANTIHYPERTENSIVE EFFECT OF AN ENDOTHELIN RECEPTOR ANTAGONIST IN DEOXYCORTICOSTERONE ACETATE SALT SHR
    LI, JS
    SVENTEK, P
    TURGEON, A
    REUDELHUBER, T
    TOUYZ, RM
    SCHIFFRIN, EL
    HYPERTENSION, 1995, 25 (06) : 1377 - 1377
  • [5] Omapatrilat increases renal endothelin in deoxycorticosterone acetate-salt hypertensive rats
    Elmarakby, AA
    Morsing, P
    Pollock, JS
    Pollock, DM
    VASCULAR PHARMACOLOGY, 2003, 40 (05) : 253 - 259
  • [6] ANTIHYPERTENSIVE ACTIVITY OF ALACEPRIL IN SPONTANEOUSLY HYPERTENSIVE RATS AND DEOXYCORTICOSTERONE ACETATE-SALT HYPERTENSIVE RATS AND DOGS
    TAKEYAMA, K
    MINATO, H
    FUKUYA, F
    KAWAHARA, S
    HOSOKI, K
    KADOKAWA, T
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1985, 35-2 (10): : 1507 - 1512
  • [7] Effect of pravastatin on nephroprotection in deoxycorticosterone acetate-salt hypertensive rats
    Kang, Chih-Sen
    Chang, Nen-Chung
    Chang, Shen-Tien
    Lin, Chih-Chan
    Lee, Tsung-Ming
    JOURNAL OF HYPERTENSION, 2009, 27 (11) : 2232 - 2243
  • [8] Antihypertensive and antioxidant effects of protocatechuic acid in deoxycorticosterone acetate-salt hypertensive rats
    Safaeian, Leila
    Emami, Reyhaneh
    Hajhashemi, Valiollah
    Haghighatian, Zahra
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 100 : 147 - 155
  • [9] Omapatrilat increases urinary endothelin excretion in deoxycorticosterone acetate-salt hypertensive rats
    Elmarakby, AA
    Loomis, ED
    Morsing, P
    Pollock, JS
    Pollock, DM
    FASEB JOURNAL, 2003, 17 (04): : A96 - A96
  • [10] Endothelin enhances and inhibits adrenal catecholamine release in deoxycorticosterone acetate-salt hypertensive rats
    Lange, DL
    Haywood, JR
    Hinojosa-Laborde, C
    HYPERTENSION, 2000, 35 (01) : 385 - 390